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Antigen presentation: TAP dances with ATP
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Assembly of antigen-presenting complexes between
class I MHC molecules and peptide requires formation
of a complex between the ‘ABC’ peptide transporter,
TAP, and newly synthesized class I molecules. Recent
studies have provided new insights into the role of ATP
in peptide binding, transport and release.
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The antigen-recognising part of the immune system has
two main arms: the B lymphocytes which produce anti-
bodies, and two types of T lymphocyte, the ‘helper’ T
cells which promote the maturation of antibody-produc-
ing B cells and the ‘cytotoxic’ T cells which kill virus-
infected and tumour cells. The most important function
of the immune system — distinguishing between healthy
and abnormal tissue — fall primarily to T cells. Cytotoxic T
cells perform this task via their interaction with class I
molecules of the major histocompatibility complex
(MHC), which bind antigenic peptides within the cell
and present them at the cell surface. The assembly of
class I MHC molecules is a complex affair, dependent on
protein degradation in the cytosol and transport of the
resulting peptides into the lumen of the endoplasmic
reticulum (ER). The import of peptides into the ER is
mediated by the transporter associated with antigen pro-
cessing (TAP), a member of the ATP-binding cassette
(ABC) family of transporters. Recent studies [1,2] have
provided new insight into the behaviour of TAP during
peptide–class I molecule assembly, particularly the role
ATP plays in regulating transitions between different
conformational states of TAP.
The ABC transporter family
ABC transporters form the largest and most diverse family
of membrane-spanning transport proteins [3]. This family
is of ancient evolutionary origin — members have been
identified throughout the animal and plant kingdoms and
in bacteria. ABC transporters span the external mem-
branes of prokaryotic cells and both external and internal
membranes of eukaryotes. Despite billions of years of
divergence, ABC transporters can readily be recognised
by their distinctive modular structure, with two large,
multi-membrane-spanning domains and two smaller, L-
shaped nucleotide-binding domains (Figure 1). The
membrane-spanning domains contain sequences which
impart substrate specificity, whereas the nucleotide-
binding domains power transport by hydrolysing ATP [4,5]. 
Despite their shared architecture, ABC transporters are
responsible for the movement across membranes of a
diverse set of substrates, including proteins, sugars, fatty-
acids, vitamins, pigments and ions. Examples of well-
known ABC proteins are the bacterial histidine and maltose
transporters, the yeast a mating factor transporter, the P-gly-
coprotein associated with multidrug resistance and the
cystic fibrosis transmembrane conductance regulator
(CFTR). Many mammalian ABC transporters have been
discovered in the last decade, including the hepatic canalic-
ular multispecific organic anion transporter, the pancreatic
sulfonylurea receptor, and the cholesterol efflux regulatory
protein. Like the CFTR, many of the newly identified
mammalian transporters are associated with genetic disease
and are the subject of intense scientific and clinical interest.
We focus here on the ‘transporter associated with antigen
processing’ — TAP — an ABC transporter with a unique
and central role in the immune system.
TAP and peptide transport
Cytotoxic T cells are critical to the normal functioning of
our immune system as they are responsible for killing
both virus-infected and tumourigenic cells. As men-
tioned above, cytotoxic T cells perform this vital func-
tion by sampling the protein content of the cell, in the
form of small peptides bound to MHC class I molecules.
MHC class I molecules — unlike the class II molecules
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Organisation of the TAP heterodimer, an ER-resident ABC transporter.
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recognized by helper T cells — are constitutively expressed
on the surface of most nucleated cells. When a cytotoxic T
cell recognizes a complex between an MHC class I mole-
cule and a foreign or altered peptide, the cytotoxic cell is
triggered to kill its target and thereby eliminate a potential
source of new infectious virus particles or tumour cells.
The synthesis and assembly of class I molecules is a
complex process [6]. The class I polypeptides are co-trans-
lationally inserted into the ER by the usual (Sec61) translo-
cation machinery. They cannot fold or leave the ER,
however, until the class I molecule is stabilized by a short
peptide which binds to a pocket formed by polymorphic
residues in the amino-terminal half of the class I molecule.
Most class I-binding peptides are generated in the cytosol
by the normal degradative activity of proteasomes, and
these peptides must then be delivered to nascent class I
molecules in the ER. This crucial transport step is per-
formed by the TAP transporter. 
TAP is currently the only known ABC transporter in the
ER membrane. Unusually for a mammalian transporter,
TAP is a heterodimer with two distinct subunits, TAP1
and TAP2. The peptide-binding site of TAP is formed by
residues on the membrane-spanning domains of both
TAP1 and TAP2 [7]. This binding site is promiscuous
and can accommodate a wide variety of peptides, ranging
in length from 8–16 residues. There is, however, some
peptide selectivity exerted by the amino-terminal
residues, particularly at position 2, and by the carboxyl
terminal residues [8].
TAP and the class I loading complex
The view that TAP plays a pivotal role in class I assembly
derives from the observation that it not only delivers
peptide to the ER, but also forms the nucleus of a large
‘loading complex’ critical for class I maturation (Figure 2).
This cluster of proteins includes unfolded class I
molecules, the general molecular chaperones of the ER,
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The TAP—class I loading complex. Newly synthesised class I heavy
chains combine with β2-microglobulin to form an incompletely folded
class I molecule. These immature class I molecules bind to TAP in
association with tapasin and the ER chaperones calreticulin and
Erp57. TAP delivers proteasome generated peptides from the cytosol
to the waiting class I molecules. When a class I molecule binds a
suitable peptide, it completes the folding process and is released
from the loading complex.
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calreticulin and Erp57, and the tapasin protein, which
appears to be dedicated to class I assembly [9]. The class I
loading complex is a dynamic assembly in which unfolded
class I molecules and associated chaperones are delivered
to TAP, become transiently associated, and are then
released again as the class I molecules bind peptide and
complete the folding process.
Recent measurements of the lateral diffusion of class I
molecules in the ER membrane have shown that class I
molecules associated with the TAP complex diffuse much
more slowly than free class I molecules [10], suggesting
that the TAP complex is an extremely large structure [10].
Although a minimal estimate of loading complex stoi-
chiometry has been published [11], precise determination
of its composition and stoichiometry are complicated by
the fluid nature of the loading complex.
ATP: energy source and allosteric regulator of TAP
Although it has been almost ten years since TAP was
identified as the class I peptide transporter, little progress
has been made in characterising the actual mechanism of
peptide transport and the steps leading to class I release.
This is beginning to change, however, as illustrated by
two recent studies [1,2] which have provided new insights
into the role of ATP in TAP function. Van Endert [1]
found that nucleotides and peptide play a critical role in
stabilizing the TAP heterodimer. TAP is unstable at
physiological temperate (37°C), but it can be stabilized by
both peptide and nucleotides. This effect appears to be
mediated through the TAP1 polypeptide.
As recently reported in Current Biology, Knittler et al. [2]
investigated the effect of ATP binding on TAP function
by generating TAP molecules — derived from the rat
version of the proteins — which could not bind ATP as a
result of mutations in the ‘Walker A motif’ of the
nucleotide binding domains. When expressed in the
TAP-negative human cell line T2, the mutant TAP mol-
ecules did not promote class I maturation. Unable to
bind ATP, the mutant proteins have no source of energy
to fuel peptide transport. The mutant TAPs had a
shorter half-life than wild-type molecules, but were still
able to associate with other proteins to form apparently
normal loading complexes.
As might have been predicted, Knittler et al. [2] found
that the class I molecules were stably associated with the
mutant TAP complex, rather than transiently associated
as they are with the wild-type TAP complex. Stabilisa-
tion of the TAP–class I interaction has been observed in
other settings where peptide transport has been blocked
or disrupted, such as by viral products, proteasome
inhibitors or when there are allele-specific incompatibili-
ties between components of the loading complex [12].
The nature of the stabilisation observed by Knittler et al. [2]
was fundamentally different, however, as the class I mol-
ecules could not be dissociated from the mutant TAP
complex in vitro by conventional methods. Class I mole-
cules that co-precipitate with wild-type TAP molecules
can be dissociated by addition of an allele-specific class
I-binding peptide to the detergent lysate. The fact that
even 100 µM concentrations of peptide could not release
class I molecules from the mutant TAP complex sug-
gested that such release might be dependent on either
nucleotide binding or nucleotide hydrolysis. As the
release of folded class I molecules occurs secondary to
peptide transport, the requirement for nucleotide in this
downstream step had gone overlooked.
This unexpected result prompted a re-examination of the
role of ATP in the action of wild-type TAP molecules.
The depletion of ATP from detergent lysates, using the
enzyme apyrase, prevented class I release from wild-type
TAP in vitro; the release could be restored by addition of
ATP, ADP or a non-hydrolyzable ATP analogue. The
release of class I molecules from the TAP complex thus
requires the presence of di- or tri-phosphates, but is not
dependent on hydrolysis. This suggests that nucleotides
have a role in both regulating and powering the transport
cycle. In experiments with TAP mutants that bind but do
not hydrolyse ATP, we have also found that nucleotides
play a critical role in both the binding of peptide to TAP
and the subsequent release of class I molecules (our
unpublished data).
Another group, however, has found that nucleotides do
not appear to play a role in the dissociation of HLA-A2
from TAP (S.J. Powis, personal communication). The
HLA-A2 class I molecule binds signal-sequence-derived
peptides and associates with TAP, but it is not dependent
on TAP for peptide delivery. Powis and colleagues found
that, in transfected TAP-negative cells that produce
either a single TAP polypeptide or a truncated form of
TAP lacking the nucleotide-binding domain, release of
HLA-A2 is independent of nucleotides. The systems
used by the two groups are not, however, directly
comparable. Single TAP polypeptides may not undergo
the same conformational changes as the complete
TAP1–TAP2 heterodimer. Furthermore, the absence of a
nucleotide binding domain may release class I from the
usual control mechanisms.
The most surprising observation made by Knittler et al. [2]
was that peptide binding was disrupted in the mutant TAP
molecules. Previous studies on wild-type TAPs — again
using apyrase for ATP depletion — showed that, while
peptide translocation requires the energy of ATP hydroly-
sis, peptide binding to TAP is ATP independent [13,14].
The inability of the mutant TAP molecules to bind
peptide seems to directly contradict these findings. As
Knittler et al. [2] did not determine whether ATP depletion
prevented peptide binding in their wild-type cells, this
issue remains unresolved. But as discussed below, a role for
nucleotides as allosteric regulators of substrate binding is
not without precedent among ABC transporters. A possible
explanation for these seemingly contradictory findings is
that wild-type TAP molecules have ATP-binding sites that
apyrase cannot access, so that — unlike the mutant mole-
cules that lack a nucleotide-binding domain altogether —
wild-type TAP molecules still bind some nucleotide even
after apparent nucleotide depletion [15,16] (Figure 3).
Multiple conformations of ABC transporters
Taken together, these results suggest that ATP is
required, not only for powering peptide transport, but
also for regulating transitions between different confor-
mational states of the TAP transporter. Knittler et al. [2]
speculate that the rate of nucleotide hydrolysis and
exchange could play an important role in coordinating the
transport of peptide with the folding and release of class I
molecules. The conversion of ATP to ADP, and its
subsequent exchange for ATP, could trigger a series of
conformational changes which propagate into the mem-
brane-spanning domains. Such a cycle of regular,
repeated conformational transitions might help to syn-
chronise the arrival of peptide with the subsequent —
and still uncharacterised — events in which peptide is
transferred to nascent class I molecules and the disul-
phide bonds characteristic of a mature class I molecule
are formed.
What other evidence might support such a model?
Nucleotide-driven conformational changes have long
been presumed to be a feature of ABC transporter
function [17]. The best and most detailed evidence for
such conformational transitions comes from studies of P-
glycoprotein and CFTR [17,18]. The biochemical robust-
ness of P-glycoprotein, in particular, has made it possible
to study its conformation using a wide variety of
approaches, such as spectroscopy, deuterium–hydrogen
exchange, protease sensitivity, chemical cross-linking and
reactivity with a conformation-sensitive antibody. The
results obtained using these different methods all support
the view that P-glycoprotein undergoes large conforma-
tional changes as it binds ATP or ADP. It is also clear that
P-glycoprotein substrates, such as vinblastine or vera-
pamil, also trigger conformational changes, and that these
are distinct from those induced by nucleotide binding.
Similar observations have been made with CFTR: the
frequency and duration of CFTR chloride channel
opening was seen to be regulated by its nucleotide-
binding domains, which furthermore appear functionally
distinct, each responsible for different properties of the
wild-type channel [19,20].
For both P-glycoprotein and CFTR, it has been possible
to build models which incorporate ATP-binding and
hydrolysis in discrete steps of the drug transport or
chloride conduction cycle [18]. A central feature of both
models is the strong interaction observed between the
two nucleotide-binding domains. ATP hydrolysis at one
nucleotide-binding domain promotes nucleotide
exchange on the other. In the initial state, the transporter
is thought to have ATP bound to the amino-terminal
nucleotide-binding domain, NBD1, and ADP bound to
the carboxy-terminal nucleotide-binding domain, NBD2.
Nucleotide hydrolysis on NBD1 allows ADP to be
released from NBD2, which can then bind ATP and
undergo a round of ATP hydrolysis. This cooperative
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ATP is an energy source and allosteric regulator of TAP. Although ATP
is required for peptide transport by TAP, it also has a hydrolysis-
independent role in regulating TAP’s ability to bind peptides and release
class I. The need for TAP-mediated transport can be circumvented by
adding class I-binding peptides to detergent lysates prepared from
TAP-expressing cells. (a) Under these conditions, wild-type TAP binds
peptides and releases class I. (b) Depleting the lysate of ATP and ADP
with apyrase blocks class I dissociation. (c) Mutant TAP molecules,
which cannot bind ATP/ADP, neither bind peptide nor release class I,
indicating a steric requirement for nucleotide in this process.
interaction between the two nucleotide-binding domains
is thought to drive the ABC transporter through an
ordered set of conformational changes in which the sub-
strate is delivered across the lipid bilayer and the trans-
porter returned to its initial state, ready to begin another
transport cycle.
This type of mechanistic detail is not yet available for TAP,
and it remains to be determined whether the two
nucleotide-binding domains of TAP show cooperativity,
and whether they have distinct functions. Knittler et al. [2]
have, however, made an important first step towards
constructing such a mechanical model of TAP function. By
suggesting that both peptide binding and class I release
require nucleotide, and that this requirement is not related
to nucleotide hydrolysis, they have provided an important
new insight into TAP function. These exciting observations
open the door to a large number of future experiments dis-
secting the function of TAP’s two nucleotide-binding
domains and assessing their individual roles in coordinating
peptide transport with class I assembly.
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